Cannabis exposure in early pregnancy alters infant brain connectivity

This observational study examined whether prenatal cannabis exposure (PCE) affects brain development in newborns by measuring THC metabolites in maternal urine during early pregnancy. Researchers collected biological samples from 42 Black mother-infant pairs at 8-14 weeks of gestation and performed brain imaging scans on the infants at approximately one month old. The study found that higher levels of THC metabolites in early pregnancy were significantly associated with altered brain connectivity patterns in three key regions: the hippocampus (memory and spatial processing), insula (emotional processing), and caudate (motor control and reward processing). These findings suggest that cannabis exposure during the critical early pregnancy window may influence how different brain regions communicate with each other.

An important nuance emerged from the analysis: while the brain connectivity changes were statistically significant, they were not correlated with measurable differences in newborn behavior as assessed through clinical neurological testing. This suggests that the neural changes detected by brain imaging may not yet translate into observable behavioral differences at one month of age. The researchers controlled for maternal psychosocial factors like depression and stress, meaning the connectivity effects appear related to cannabis exposure itself rather than other maternal health factors. This is significant because it provides the first biological evidence of prenatal cannabis effects on infant brain structure in a historically underrepresented population.

The study's implications are substantial for public health messaging about cannabis use during pregnancy. While previous research suggested prenatal cannabis exposure might affect fetal development, this work provides objective neuroimaging evidence of specific brain connectivity changes in human newborns. However, the lack of behavioral correlation at one month means the long-term clinical significance remains unclear—these early neural changes may normalize over time, or they may become apparent as the child develops.